E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma
Bao-Hua Zhang1, Han Chen, Xiao-Ping Yao
1Eastern Hepatobiliary Surgery Hospital, Second Military Medical University of PLA, Shanghai 200438, China. zhbh_1@163.net
Objective:
To study the significance of E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma (HCC).
Methods:
Flow cytometry and immunohistochemistry were used to detect the expression of E-selectin and its ligand-sLeX in both HCC cell lines and human HCC tissues.
Results:
The positive rate of E-selectin in vascular endothelial cells adjacent to cancer was 67.9% (19/28). The expression of E-selectin in tumors accompanied with emboli or satellite foci was significantly higher than that in tumors without emboli or satellite foci (P<0.05), and it was not related to tumor size, tumor capsule, AFP content, and the degree of differentiation. The positive expression of sLeX in SMMU-7721, PLF/PRF/5 and HepGII cell lines was 7.03%, 63.35% and 97.29% respectively. The positive cells of sLeX mainly distributed in the margin of tumor tissues. The positive expression of sLeX in HCC cells in emboli or invasive tumor tissues was much higher than in Primary foci.
Conclusion:
E-selectin and its ligand-sLeX are closely correlated with the metastasis of HCC.
Related Concept Videos
Selectins
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Targeted Cancer Therapies
There are several types of targeted therapies against specific...


